End Cash: The amount of cash held by the company for the given period.
Aptose Biosciences, Inc. (APTOF) had End Cash of $4.74M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-5.54M |
|
-- |
|
-- |
|
$5.46M |
|
$-5.46M |
|
$-0.08M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.46M |
|
$-5.36M |
|
2.13M |
|
2.13M |
|
$-2.61 |
|
$-2.61 |
|
| Balance Sheet Financials | |
$6.97M |
|
$0.02M |
|
$0.50M |
|
$7.47M |
|
$6.32M |
|
$8.46M |
|
$8.54M |
|
$14.86M |
|
$-7.39M |
|
$-7.39M |
|
$-7.39M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-2.79M |
|
-- |
|
$0.83M |
|
$6.71M |
|
|
End Cash |
$4.74M |
$-1.96M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.10 |
|
-- |
|
-- |
|
7.92 |
|
-1.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
74.98% |
|
74.98% |
|
-74.23% |
|
-518.52% |
|
$-2.90 |
|
$-1.31 |
|
$-1.31 |
|